Global Pulmonary Embolism Therapeutics Market 2019-2023
SKU ID : TNV-14253037 | Publishing Date : 06-May-2019 | No. of pages : 119
Detailed TOC of Global Pulmonary Embolism Therapeutics Market 2019-2023
ART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: MARKET SEGMENTATION BY ROA
Market segmentation by RoA
Comparison by RoA
Oral - Market size and forecast 2018-2023
Parenteral - Market size and forecast 2018-2023
Market opportunity by RoA
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 11: MARKET TRENDS
Increasing research on anticoagulant antidotes
Strategic alliances
Extensive research on regenerative therapies
PART 12: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive scenario
PART 13: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Co.
Daiichi Sankyo Co. Ltd.
F. Hoffmann-La Roche Ltd.
Johnson & Johnson Services Inc.
PART 14: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: RoA - Market share 2018-2023 (%)
Exhibit 18: Comparison by RoA
Exhibit 19: Oral - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Oral - Year-over-year growth 2019-2023 (%)
Exhibit 21: Parenteral - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Parenteral - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by RoA
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
Exhibit 29: Top 3 countries in North America
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in Europe
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Asia
Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in ROW
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Boehringer Ingelheim International GmbH - Vendor overview
Exhibit 48: Boehringer Ingelheim International GmbH - Business segments
Exhibit 49: Boehringer Ingelheim International GmbH - Organizational developments
Exhibit 50: Boehringer Ingelheim International GmbH - Geographic focus
Exhibit 51: Boehringer Ingelheim International GmbH - Segment focus
Exhibit 52: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 53: Boehringer Ingelheim International GmbH - Key customers
Exhibit 54: Bristol-Myers Squibb Co. - Vendor overview
Exhibit 55: Bristol-Myers Squibb Co. - Business segments
Exhibit 56: Bristol-Myers Squibb Co. - Organizational developments
Exhibit 57: Bristol-Myers Squibb Co. - Geographic focus
Exhibit 58: Bristol-Myers Squibb Co. - Key offerings
Exhibit 59: Bristol-Myers Squibb Co. - Key customers
Exhibit 60: Daiichi Sankyo Co. Ltd. - Vendor overview
Exhibit 61: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 62: Daiichi Sankyo Co. Ltd. - Organizational developments
Exhibit 63: Daiichi Sankyo Co. Ltd. - Geographic focus
Exhibit 64: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 65: Daiichi Sankyo Co. Ltd. - Key customers
Exhibit 66: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 67: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 68: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 69: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 70: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 71: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 72: F. Hoffmann-La Roche Ltd. - Key customers
Exhibit 73: Johnson & Johnson Services Inc. - Vendor overview
Exhibit 74: Johnson & Johnson Services Inc. - Business segments
Exhibit 75: Johnson & Johnson Services Inc. - Organizational developments
Exhibit 76: Johnson & Johnson Services Inc. - Geographic focus
Exhibit 77: Johnson & Johnson Services Inc. - Segment focus
Exhibit 78: Johnson & Johnson Services Inc. - Key offerings
Exhibit 79: Johnson & Johnson Services Inc. - Key customers
Exhibit 80: Validation techniques employed for market sizing
Exhibit 81: Definition of market positioning of vendors
Keyplayers in Global Pulmonary Embolism Therapeutics Market 2019-2023
Boehringer Ingelheim International GmbHBristol-Myers Squibb Co.
Daiichi Sankyo Co. Ltd.
F. Hoffmann-La Roche Ltd.
Johnson & Johnson Services Inc.